OV
O2h Ventures
Venture CapitalActiveo2h has developed an engine for seeding a pipeline of early stage life science assets through research collaborations.
11
Investments
2
Exits
$100M
AUM
18.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for O2h Ventures.
Investment Thesis & Strategy
O2h Ventures invests in various stages of life science companies, focusing on early-stage assets developed through research collaborations.
Investment Activity
Deals per year over the last 6 years
2
20170
20181
20190
20203
20214
2022Portfolio Companies
Selected investments from their portfolio of 11 companies
S
Soma Bioscience
Biotech · Seed, 2022
M
MicroBioSensor
Biotech · Seed, 2022
F
Focal Point
Biotech · Series A, 2022
Q
Qureight
Healthcare · Series A, 2022
A
Aptus Clinical
Biotech · Series A, 2021
C
Cambridge GaN Devices
Cleantech · Series A, 2021
B
Baseimmune
Biotech · Seed, 2021
E
Elasmogen
Biotech · Series A, 2019
E
Exonate
Biotech · Series A, 2017
P
PhoreMost
Biotech · Series A, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
FocalPointAcquisition2022—
Symphony Environmental TechnologiesIPO2013—
Frequently Asked Questions
O2h Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
General Catalyst
Cambridge, United States · 737 deals
Atlas Venture
Cambridge, United States · 514 deals
F-Prime Capital
Cambridge, United States · 228 deals
MPM Capital
Cambridge, United States · 223 deals
Accomplice
Cambridge, United States · 222 deals
Flagship Pioneering
Cambridge, United States · 213 deals